ASHLEY HALE: Open Payments
NPI 1174886428 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 24 payments from 19 companies in 2025. Trend: 2023 $314 · 2024 $956 · 2025 $700
Food & beverage: $613Education: $87
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $149 |
| AstraZeneca Pharmaceuticals LP | 3 | $125 |
| GENZYME CORPORATION | 2 | $67 |
| Alexion Pharmaceuticals, Inc. | 2 | $52 |
| TAIHO ONCOLOGY, INC. | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Geron Corporation | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Celgene Corporation | 1 | $22 |
Products named: OSTEOCOOL RF ABLATION SYSTEM, LYNPARZA, SARCLISA, ULTOMIRIS, Enhertu, LONSURF, PLUVICTO, RYTELO.
Industry payments across GA — which companies pay providers there.
